Skip to main content
Top

2009 | OriginalPaper | Hoofdstuk

3 Colitis ulcerosa

Auteurs : mw.dr. M.J. Zaagsman van Buuren, mw. P.A.M. Slegers van der Plas

Gepubliceerd in: Zakboek ziektebeelden Gastro-enterologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Colitis ulcerosa (cu) is een chronische ontsteking van het slijmvlies van het colon (dikke darm). Het is een continue oppervlakkige ontsteking van het slijmvlies van de dikke darm, waarbij het rectum vrijwel altijd is ontstoken (proctitis). cu begint in het rectum (endeldarm) en kan zich dan uitbreiden over de hele dikke darm. Meestal (in 75 procent van de gevallen) raakt alleen het linkercolondeel betrokken, in veel gevallen ook blijft de ontsteking beperkt tot het rectum (proctitis). De ziekte kan op iedere leeftijd voorkomen, maar wordt het meest gezien tussen het 15e en 40e levensjaar.
Literatuur
go back to reference Baumgart DC, Sandborn WJ. Inflammatory Bowel Disease: clinical aspects and established and evolving therapies. Lancet. 2007:369;1641–57.CrossRefPubMed Baumgart DC, Sandborn WJ. Inflammatory Bowel Disease: clinical aspects and established and evolving therapies. Lancet. 2007:369;1641–57.CrossRefPubMed
go back to reference Beers MH, Mark H, Berkow R, editors. The Merck manual of diagnosis and therapy. 17th ed. Whitehouse Station, NJ: Merck Research Laboratories; 1999. Beers MH, Mark H, Berkow R, editors. The Merck manual of diagnosis and therapy. 17th ed. Whitehouse Station, NJ: Merck Research Laboratories; 1999.
go back to reference Cohen RD. A meta-analysis and overview of the literature on treatment options for left-side ulcerative colitis and proctitis. Am J Gastroenterol. 2000;95:1263–76.CrossRefPubMed Cohen RD. A meta-analysis and overview of the literature on treatment options for left-side ulcerative colitis and proctitis. Am J Gastroenterol. 2000;95:1263–76.CrossRefPubMed
go back to reference College voor zorgverzekeringen. Farmacotherapeutisch Kompas. Amstelveen; 2002. College voor zorgverzekeringen. Farmacotherapeutisch Kompas. Amstelveen; 2002.
go back to reference Derijks L. Thiopurines in inflammatory bowel disease. New strategies for optimization of pharmacotherapy [proefschrift]. Amsterdam; 2005. Derijks L. Thiopurines in inflammatory bowel disease. New strategies for optimization of pharmacotherapy [proefschrift]. Amsterdam; 2005.
go back to reference Franchimont D, Kino T, Galon J, Meduri GU, Chrousos G. Glucocorticoids and inflammation revisited; the state of the art. Neuroimmuno-modulation 2002–2003;10:247–60. Franchimont D, Kino T, Galon J, Meduri GU, Chrousos G. Glucocorticoids and inflammation revisited; the state of the art. Neuroimmuno-modulation 2002–2003;10:247–60.
go back to reference Lennard Jones, Assesment of severity in colitis; a preliminary study. Gut. 1975;16:579–84.CrossRef Lennard Jones, Assesment of severity in colitis; a preliminary study. Gut. 1975;16:579–84.CrossRef
go back to reference Loenen A van, redactie. Farmacotherapeutisch Kompas. Diemen; College voor zorgverzekeringen; 2005. Loenen A van, redactie. Farmacotherapeutisch Kompas. Diemen; College voor zorgverzekeringen; 2005.
go back to reference Meer J van, Stehouwer CDA, redactie. Interne geneeskunde. 12e herziene druk. Houten/Diegem: Bohn Stafleu van Loghum; 2001. Meer J van, Stehouwer CDA, redactie. Interne geneeskunde. 12e herziene druk. Houten/Diegem: Bohn Stafleu van Loghum; 2001.
go back to reference Oshitani N, Kitano A, Matsumoto T, Kobayashi K. Corticosteroids for the managment of ulcerative colitis. J Gastroenterol. 1995;30:118–20.PubMed Oshitani N, Kitano A, Matsumoto T, Kobayashi K. Corticosteroids for the managment of ulcerative colitis. J Gastroenterol. 1995;30:118–20.PubMed
go back to reference Rutgeets P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462–76.CrossRef Rutgeets P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462–76.CrossRef
go back to reference Sandborn WJ, Hanauer SB. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the managment of ulcerative colitis. Aliment Pharmacol Ther. 2003;17: 29–42.CrossRefPubMed Sandborn WJ, Hanauer SB. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the managment of ulcerative colitis. Aliment Pharmacol Ther. 2003;17: 29–42.CrossRefPubMed
go back to reference Sood A, Midha V, Sood N, Kaushal V. Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial. Indian J Gastroenterol.2000;19:14–6.PubMed Sood A, Midha V, Sood N, Kaushal V. Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial. Indian J Gastroenterol.2000;19:14–6.PubMed
go back to reference Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2003;3: CD00543. Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2003;3: CD00543.
go back to reference Sutherland LR, Roth K, Beck P, May G, Makiyama K. Oral 5-aminosali-cylic acid form maintaining remission in ulcerative colitis. Cochrane Database Syst Rev. 2002;4:CD000544.PubMed Sutherland LR, Roth K, Beck P, May G, Makiyama K. Oral 5-aminosali-cylic acid form maintaining remission in ulcerative colitis. Cochrane Database Syst Rev. 2002;4:CD000544.PubMed
go back to reference Turner D, Walsh CM, Steinhart AH, Griffithes AM. Response to corticosteroids in severe ulcerative colitis; a systematic review of the literature and a meta regression. Clin Gastroenterol Hepatol. 2007;5:103–10.CrossRefPubMed Turner D, Walsh CM, Steinhart AH, Griffithes AM. Response to corticosteroids in severe ulcerative colitis; a systematic review of the literature and a meta regression. Clin Gastroenterol Hepatol. 2007;5:103–10.CrossRefPubMed
go back to reference Woude J van der. Medicamenteuze therapie van inflammatoire darmziektenI. colitis ulcerosa. Geneesmiddelenbulletin. 2006:40:29–35. Woude J van der. Medicamenteuze therapie van inflammatoire darmziektenI. colitis ulcerosa. Geneesmiddelenbulletin. 2006:40:29–35.
Metagegevens
Titel
3 Colitis ulcerosa
Auteurs
mw.dr. M.J. Zaagsman van Buuren
mw. P.A.M. Slegers van der Plas
Copyright
2009
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-7548-6_3